BIOLOGICAL RESEARCH

Lobacheva O.A., Nikitina V.B., Gutkevich E.V., Pershina A.E., Pogorelova T.V., Kazennykh T.V., Kornetova E.G. (Tomsk) Immunobiological markers of the effectiveness of antipsychotic therapy in patients with schizophrenia …………………………………………………………………………………………………….

5

Gerasimchuk E.S., Moritz A.A., Ivanov M.V., Sorokin M.Yu., Lutova N.B.(Saint Petersburg) Development of weighted factors of systemic inflammation based on hematological coefficients in patients with mental disorders ……………………………………………………………………………………………………….

13

Paderina D.Z., Mikhalitskaya E.V., Vyalova N.M., Roshchina O.V., Simutkin G.G., Ivanova S.A.(Tomsk) Polymorphism of neurotrophin genes and aggressive behavior in patients with affective disorders .…

23

Boksha I.S., Shushpanova O.V., Savushkina O.K., Prokhorova T.A., Tereshkina E.B., Vorobyeva E.A., Burbaeva G.Sh.(Moscow) Determination of blood enzyme activity and evaluation of the effectiveness of psychopharmacotherapy in children with schizophrenia spectrum disorders: a pilot study …………………….

31

Kibitov A.O., Shumskaia D.S., Pinakhina D.V., Chensky I.S., Yanushko M.G., Popov M.Yu., Zhilyaeva T.V., Mazo G.E.(Saint Petersburg) Specific metabolic and inflammatory profiles of patients with hyperglycemia in bipolar affective disorder, recurrent depression and schizophrenia: results of a transdiagnostic study …………………………………………………………………………………………………………….

43

INFORMATION TECHNOLOGY IN PSYCHIATRY

Radionov D.S., Yakovlev A.V., Karavaeva T.A., Vasilieva A.V.(Saint Petersburg) Automation of software development for psychiatry, psychotherapy and medical psychology: methodology for creating technical specifications and code generation using artificial intelligence (vibe-coding) ……………………………………….

57

CLINICAL PSYCHIATRY

Belokrylova M.F., Nikitina V.B., Rudnitsky V.A., Maltsev V.S., Sazonova O.V., Vasilieva M.G., Ivanova A.A., Tsybulskaya E.V., Lebedeva V.F., Pavlova O.A., Kazennykh T.V., Garganeeva N.P., Perchatkina O.E., Bokhan N.A.(Tomsk) Risk factors for the development and characteristics of cognitive dysfunction in patients with a history of COVID-19 infection………………………………………………………………….

71

Vasilchenko V.V., Rukavishnikov G.V., Yakovleva Ya.V., Mazo G.E.(Saint Petersburg) The influence of mental and somatic multimorbidity on suicidal tendencies in patients with affective disorders ………………….

84

Agarkov A.A., Akulinina K.A., Kisel N.I., Chernysheva K.G., Gutkevich E.V.(Tomsk) Quality of interpersonal relationships and marital satisfaction of young people prone to internet-addictive behavior ……………….

94

Shushpanova O.V., Boksha I.S., Zozulya S.A.(Moscow) Autism spectrum disorder in an adolescent with deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase of fatty acids caused by a mutation in the HADHA gene in a homozygous state (presentation of a clinical case) …………………………………………………………….

105

21

CLINICAL ADDICTOLOGY

Rakitin S.A., Usov G.M., Kurushkin M.V., Bokhan N.A.(Omsk, Tomsk) Clinical example of delayed chronic psychosis in the form of hallucinosis in a patient with 1,4-butanediol dependence …………………….

117

SUICIDOLOGY

Zotov P.B., Umansky M.S., Suldin A.M., Mateikovich M.S., Golenkov A.V., Bukhna A.G., Umansky E.M.(Tyumen, Moscow, Cheboksary) Suicidal mortality in the Tyumen Region (Western Siberia): risk factors and prevention strategies ……………………………………………………………………………………………….

126

JUBILEE……………………………………………………………………………………………………….……

139

SHPAP AUTHOR INDEX FOR 2025 ………………………………………………………………….

140